Table 1.

Patient Characteristics.

Patients	Age	Sex	Cause of LSCD	Baseline VA	Baseline Corneal Opacity Score	Baseline Central Vascularization Score	Follow-Up Time (Months)
1	37	M	Chemical burn	HM	3	1	81.3
2	18	F	Idiopathic	FC	2	2	24.7
3	83	F	Glaucoma medication	HM	0.5	0	71.0
4	69	M	Tumor excision	6/15	1	1	74.8
5	38	F	Idiopathic	FC	0.5	0	62.4
6	80	M	Glaucoma medication	6/15+1	0	0	40.9
7	32	F	Idiopathic	LP	4	4	59.6
8	33	M	Chemical burn	6/9-2	0.5	2	56.8
9	64	F	Radiotherapy for mucosa associated lymphoid tumor	HM	2	2.5	52.9
10	70	M	CIN (conjunctival intraepithelial neoplasia) Interferon and Mitomycin treatment	FC	1	0	46.3
11	79	F	CIN (conjunctival intraepithelial neoplasia) CO2 laser treatment	LP	4	4	64.2
12	40	F	Glaucoma medication and surgeries	FC	2.5	0	55.5
13	57	M	Mycosis fungoides	FC	4	2	19.1
14	51	F	Chemical burn	6/15+2	1.5	0	16.8
15	68	F	Multiple surgeries	6/18+2	2	0	43.9

LSCD—Limbal Stem Cell Deficiency, VA—Visual Acuity, MALT—Mucosa associated lymphoid tumor, CI—Conjunctival intraepithelial neoplasia.